NCT04862364

Brief Summary

For the Turkish validation Study of the Endometriosis Health Profile test (EHP-30) consisting of 30 questions, this 30-question test will be applied to 228 patients after 2 different translations to be applied after the translation of this 30-question test sworn translator to the patients who have been surgically diagnosed with endometriosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
228

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 26, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

April 26, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 28, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2021

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 26, 2021

Completed
Last Updated

August 31, 2021

Status Verified

August 1, 2021

Enrollment Period

4 months

First QC Date

April 26, 2021

Last Update Submit

August 30, 2021

Conditions

Endometriosis

Outcome Measures

Primary Outcomes (1)

  • Turkish Validation of Endometriosis Health Profile -30 (EHP-30) Test

    The Turkish validation study of the Endometriosis Health Profile -30EHP-30 test, which shows the general quality of life of endometriosis patients, will be performed and the use of Turkish language will be provided.

    3 months

Interventions

Endo Patients with Endometriosis Health Profile -30 (EHP-30) TestOTHER

The appointment of the patients consists of patients who were surgically diagnosed with Endometriosis in our clinic.

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen with Endometriosis(surgicallay diagnosed)
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Female patients between the ages of 18-45 who were surgically diagnosed with endometriosis in our clinic will be included in the study. Persons with a known psychiatric illness, pregnant or using anti-depressant medication will be excluded from the study. Patients will be asked the questions of the online EHP-30 form and the answers given will be evaluated in terms of validation.

You may qualify if:

  • being surgically diagnosed with endometriosis
  • Age between 18- 45
  • not being pregnant

You may not qualify if:

  • have been diagnosed with endometriosis by ultrasound
  • above 45 and under 18 years old
  • use psichiatrig drugs
  • being diagnosed with a psychiatric illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pinar Yalcin Bahat

Istanbul, İ̇stanbul, 34000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Endometriosis

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 26, 2021

First Posted

April 28, 2021

Study Start

April 26, 2021

Primary Completion

August 20, 2021

Study Completion

August 26, 2021

Last Updated

August 31, 2021

Record last verified: 2021-08

Locations

TU(1)